A self-rating scale for patient-percieved side effects of inhaled corticosteroids

Respiratory Research

Volumn 7, Issue , 2006, Pages

  Foster, Juliet M ^a,b   van Sonderen, Eric ^b   Lee, Amanda J ^a   Sanderman, Robbert ^b   Dijkstra, Antoon ^b   Postma, Dirkje S ^b   van der Molen, Thys ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FORMOTEROL; LONG ACTING DRUG; PREDNISOLONE; SALMETEROL; SHORT ACTING DRUG;

ADULT; ARTICLE; ASTHMA; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CORTICOSTEROID THERAPY; COUGHING; DISCRIMINANT ANALYSIS; DOSE RESPONSE; DRUG RESPONSE; DRY EYE; DRY SKIN; DRY THROAT; FACE EDEMA; FATIGUE; FEMALE; HAIR LOSS; HOARSENESS; HUMAN; INHALED CORTICOSTEROID QUESTIONNAIRE; IRRITABILITY; LARYNX DISORDER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOUTH DISEASE; MULTIPLE REGRESSION; NAIL DISEASE; PREDICTION; QUESTIONNAIRE; RANDOM SAMPLE; RATING SCALE; REPRODUCIBILITY; SCORING SYSTEM; SELF CONCEPT; SKIN BRUISING; SKIN TOXICITY; SLEEP DISORDER; SORE THROAT; STATISTICAL SIGNIFICANCE; SWEAT GLAND DISEASE; SYSTEMIC DISEASE; TASTE DISORDER; TEST RETEST RELIABILITY; THIRST; THROAT DISEASE; THRUSH; TOOTH DISEASE; VISUAL IMPAIRMENT; CROSS-SECTIONAL STUDY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATIENT; RETROSPECTIVE STUDY; STANDARDS; VALIDATION STUDY;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 33751177750     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-7-131     Document Type: Article

References (40)

1. Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, Campbell R: Resisting medicines: a synthesis of qualitative studies of medicine taking. Social Science & Medicine 2005, 61:133-155.
2. van Grunsven PM: The magnitude of fear of adverse effects as a reason for nonparticipation in drug treatment: a short review. J Asthma 2001, 38:113-119.
3. Foster JM, Aucott L, van der Werf RH, van der Meijden MJ, Schraa G, Postma DS, van der Molen T: Higher patient perceived side effects related to higher daily doses of inhaled corticosteroids in the community: A cross-sectional analysis. Respir Med 2006, 100:1318-1336.
4. Roland N, Bhalla R, Earis J: The Local Side Effects of Inhaled Corticosteroids: Current Understanding and Review of the Literature. Chest 2004, 126:213-219.
5. Lipworth B: Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis. Arch Intern Med 1999, 159:941-955.
6. Hanania NA, Chapman KR, Kesten S: Adverse effects of inhaled corticosteroids. Am J Med 1995, 98:196-208.
7. Britten N, Stevenson F, Gafaranga J, Barry C, Bradley C: The expression of aversion to medicines in general practice consultations. Social Science & Medicine 2004, 59:1495-1503.
8. FitzGerald M, Chan CK, Boulet LP: Medication Use, Asthma Control and Oropharyngeal Side Effects in a Population of Canadian Asthma Patients. Proceedings of the American Thoracic Society 2006, 3:A593.
9. Bender BG, Bender SE: Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am 2005, 25:107-130.
10. George M, Freedman T, Norfleet AL, Feldman H, Apter A: Qualitative research-enhanced understanding of patients' beliefs: Results of focus groups with low-income, urban, African American adults with asthma. Journal of Allergy and Clinical Immunology 2003, 111:967-973.
11. Chambers CV, Markson L, Diamond JJ, Lasch L, Berger M: Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med 1999, 93:88-94.
12. Boulet LP, FitzGerald M, Chan CK: Physicians Perception and Management of Oro-Pharyngeal Symptoms in Asthmatic Patients Using Inhaled Corticosteroids. Proceedings of the American Thoracic Society 2006, 3:A593.
13. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, Ownby DR, Johnson CC: Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004, 114:1288-1293.
14. Cochrane GM: Compliance and outcomes in patients with asthma. Drugs 1996, 52 Suppl 6:12-19.
15. Lindstrom E, Lewander T, Malm U, Malt UF, Lublin H, Ahlfors UG: Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia - Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERSPat). Nordic Journal of Psychiatry 2001, 55 Suppl 44:5-69.
16. Ahlfors UG: UKU-SERS-Pat and UKU-ConSat - two new rating scales for side effects of psychotropic drugs and consumer satisfaction with care. Nordic Journal of Psychiatry 2001, 55:3-3.
17. Day JC, Wood G, Dewey M, Bentall RP: A Self-Rating Scale for Measuring Neuroleptic Side-Effects - Validation in A Group of Schizophrenic-Patients. British Journal of Psychiatry 1995, 166:650-653.
18. Streiner D, Norman G: Health measurement scales. A practical guide to their development and use Oxford, Oxford University Press; 1995.
19. Ghiselli EE C JP,Zedeck S.: Measurement Theory for the Behavioral Sciences San Francisco, W.H. Freeman and Company; 1981.
20. Kirshner B, Guyatt G: A methodological framework for assessing health indices. Journal of Chronic Diseases 1985, 38:27-36.
21. The Inhaled Corticosteroid Questionnare Website 2006 [http://www.ICQscale.nl].
22. Geijer RMM, Van Hensbergen W, Bottema BJAM, van Schayck CP, Sachs APE, Smeele IJM, Thiadens HA, van Weel C, Rosmalen CFH: NHG-standaard Astma bij volwassenen: behandeling. Huisarts en Wetenschap 2001, 44:153.
23. Mollmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stockmann R, Barth J, Lawlor C, Mollmann AC, Derendorf H, Hochhaus G: Single-dose and steadystate pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects. J Clin Pharmacol 2001, 41:1329-1338.
24. NAEPP: National Institutes of Health, National Asthma Education & Prevention Program. Volume (NIH Publication No. 02-5075).. Bethesda, MD, Government Printing Office; 2002.
25. Juniper E, Bousquet J, Abetz L, Bateman E: Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respiratory Medicine 2006, 100:616-621.
26. Sanderman R, Arrindell WA, Ranchor A, Eysenck HJ, Eysenck SBG: Het meten van persoonlijkheidskenmerken met de Eysenck Personality Questionnaire:een handleiding. Groningen, Noordelijk Centrum voor Gezondheidsvraagstukken, Rijksuniversiteit Groningen; 1995.
27. Watson D, Clark LA, Tellegen A: Development and Validation of Brief Measures of Positive and Negative Affect - the Panas Scales. Journal of personality and social psychology 1988, 54:1063-1070.
28. Cattell RB: Scree Test for Number of Factors. Multivariate Behavioral Research 1966, 1:245-276.
29. Juniper EF, Buist AS, Cox FM, Ferrie PJ, King DR: Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999, 115:1265-1270.
30. Costa PT Jr., McCrae RR: Neuroticism, somatic complaints, and disease: is the bark worse than the bite? J Pers 1987, 55:299-316.
31. Williams P, Wiebe D: Individual differences in self-assessed health: Gender, neuroticism and physical symptom reports. Personality and Individual Differences 2000, 28:823-835.
32. Williams PG, Colder CR, Lane JD, McCaskill CC, Feinglos MN, Surwit RS: Examination of the neuroticism-symptom reporting relationship in individuals with type 2 diabetes. Personality and Social Psychology Bulletin 2002, 28:1015-1025.
33. Flemons WW, Reimer MA: Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am J Respir Crit Care Med 1998, 158:494-503.
34. Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H, Izumi T: A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 159:1874-1878.
35. Toogood JH, Frankish CW, Jennings BH, Baskerville JC, Borga O, Lefcoe NM, Johansson SA: A study of the mechanism of the anti-asthmatic action of inhaled budesonide. J Allergy Clin Immunol 1990, 85:872-880.
36. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SA: Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 1989, 84:688-700.
37. Carr RE, Lehrer PM, Hochron SM: Panic symptoms in asthma and panic disorder: a preliminary test of the dyspnea-fear theory. Behav Res Ther 1992, 30:251-261.
38. Autio P, Karjalainen J, Risteli L, Risteli J, Kiistala U, Oikarinen A: Effects of an inhaled steroid (budesonide) on skin collagen synthesis of asthma patients in vivo. Am J Respir Crit Care Med 1996, 153:1172-1175.
39. Kelly HW, Nelson HS: Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 2003, 112:469-478.
40. Kroenke K: Studying symptoms: sampling and measurement issues. Ann Intern Med 2001, 134:844-853.